Table 21: Patient Characteristics. Interstitial Laser Coagulation Versus TURP.
| Study, Year | Patients, No (Treatment, control) | Inclusion criteria | Prostate size Mean (SD), mL | Mean follow-up (Years) | No. available for follow-up |
|---|---|---|---|---|---|
| Kursh et al. 2003 (37) Multicentre trial |
72 (37, 35) |
Patients with BPH with prostate size ≤75 cc; IPSS≥13; Qmax <15 for 2 seconds; PVR 30–300 mL; prostatic length ≥1.5 cm | ILC: 41.5 TURP: 40 NS |
2 | ILC: 28 TURP: 30 |
| Liedberg et al. 2003 (71) | 31 (20, 11) |
Patients with moderate to severe symptomatic BPH; IPSS≥12; Qmax ≤15 mL/s | NR | 1 | NR |
| Norby et al. 2002 (56) 3-arm study, 2 centres |
72 (48, 24) Third arm: 46 to TUMT |
Patients with BPH 50 years or older; IPSS ≥ 7; QOL ≥ 3; Qmax <12 mL/s | ILC: 44 TURP: 44 |
0.5 | 44 22 |
BPH refers to benign prostatic hyperplasia; ILC, interstitial laser coagulation; IPSS, International Prostate Symptom Score; NR, not reported; PVR, postvoid residual; Qmax, maximum flow rate; SD, standard deviation; TURP, transurethral resection of the prostate